Carbohydrate Polymers 92 (2013) 184–191
Contents lists available at SciVerse ScienceDirect
Carbohydrate Polymers
journal homepage: www.elsevier.com/locate/carbpol
Agaricus bisporus fucogalactan: Structural characterization and pharmacological
approaches
Andrea C. Ruthes a , Yanna D. Rattmann a,b , Simone M. Malquevicz-Paiva a , Elaine R. Carbonero c ,
Marina M. Córdova d , Cristiane H. Baggio e , Adair R.S. Santos d , Philip A.J. Gorin a , Marcello Iacomini a,∗
a
Departamento de Bioquímica e Biologia Molecular, Universidade Federal do Paraná, CP 19046, CEP 81531-980, Curitiba, PR, Brazil
Departamento de Saúde Comunitária, Universidade Federal do Paraná, Rua Padre Camargo 280, CEP 80060-240, Alto da Glória, Curitiba, PR, Brazil
c
Departamento de Química, Universidade Federal de Goiás, Campus Catalão, 75704-020 Catalão, GO, Brazil
d
Laboratório de Neurobiologia da Dor e Inflamação, Departamento de Ciências Fisiológicas, Universidade Federal de Santa Catarina, Campus Universitário, Trindade, 88040-900
Florianópolis, SC, Brazil
e
Departamento de Farmacologia, Universidade Federal do Paraná, CP 19031, CEP 81531-980, Curitiba, PR, Brazil
b
a r t i c l e
i n f o
Article history:
Received 8 July 2012
Received in revised form 13 August 2012
Accepted 19 August 2012
Available online 24 August 2012
Keywords:
Edible mushroom
Agaricus bisporus
Fucogalactan
Sepsis
Anti-inflammatory
Pain
a b s t r a c t
The fucogalactan from Agaricus bisporus (EFP-Ab) obtained on aqueous extraction followed by purification had Mw 37.1 × 104 g mol−1 relative to a (1→6)-linked ␣-d-Galp main-chain partially methylated
at HO-3, and partially substituted at O-2 by nonreducing end-units of ␣-l-Fucp or -d-Galp. EFP-Ab
also inhibited significantly the neurogenic and inflammatory phases of formalin-induced licking, however, the antinociceptive effect was more pronounced against the inflammatory phase with ID50 of
36.0 (25.8–50.3) mg kg−1 . In addition, EFP-Ab decreased the lethality induced by CLP. Its administration reduced the late mortality rate by 40%, prevented neutrophil accumulation in lungs and markedly
decreased iNOS and COX-2 protein expression by ileum cells. These data show for the first time that EFPAb has significant anti-sepsis, antinociceptive and anti-inflammatory actions, which seems to be related
to the decreased iNOS and COX-2 expression. Collectively, the present results demonstrate that EFP-Ab
could constitute an attractive molecule of interest for the development of new drugs.
© 2012 Elsevier Ltd. All rights reserved.
1. Introduction
Mushrooms are currently evaluated for their nutritional value
and acceptability as well as for their pharmacological properties.
The benefits of mushroom compounds on different clinical conditions have attracted the interest of the scientific community in
the last decade in order to understand the molecular mechanisms
responsible for their actions (Wasser, 2010). Polysaccharides and
other mushroom compounds such as proteins, lypopolysaccharides, glycoproteins and secondary metabolites have been classified
as molecules that have potent effects on the immune system
(Wasser, 2010). In pursuit of such molecules, several polysaccharides have been isolated from basidiomycetes, such as linear
or branched glucans and heterogalactans, which can contain Omethyl groups or a variety of side chains (Wasser, 2002; Zhang, Cui,
Cheung, & Wang, 2007). Most heterogalactans have a main chain
composed of (1→6)-linked ␣-d-Galp units with mainly fucose or
mannose as substituent (Carbonero, Gracher, Komura, et al., 2008;
Carbonero, Gracher, Rosa, et al., 2008; Rosado et al., 2003; Smiderle
∗ Corresponding author. Tel.: +55 41 3361 1655; fax: +55 41 3266 2042.
E-mail address: iacomini@ufpr.br (M. Iacomini).
0144-8617/$ – see front matter © 2012 Elsevier Ltd. All rights reserved.
http://dx.doi.org/10.1016/j.carbpol.2012.08.071
et al., 2008; Wasser, 2002; Zhang et al., 2007), although there are
few studies relating their detailed structure and biological activity.
Some of these polysaccharides have been evaluated as biological response modifiers, especially for their antitumor activity
(Moradali, Mostafavi, Ghods, & Hedjaroude, 2007; Wasser & Weis,
1999; Zhang et al., 2007). Some reports have shown that extracts
from mushrooms can have other effects, such as anti-inflammatory
and antinociceptive activity (Dore et al., 2007; Komura et al.,
2010; Moro et al., 2012; Queiroz et al., 2010; Ruthes, Rattmann,
Carbonero, Gorin, & Iacomini, 2012; Smiderle et al., 2006, 2008).
However, it is not possible to attribute a relation between structure and activity, because most of the investigations were carried
out using crude polysaccharide extracts (Lindequist, Niedermeyer,
& Julich, 2005; Poucheret, Fons, & Rapior, 2006). Recent studies
concerned anti-inflammatory and antinociceptive effects of fucogalactans, fucomannogalactans, and mannogalactans isolated from
Agaricus brasiliensis and Agaricus bisporus var. hortensis (Komura
et al., 2010), Lentinus edodes (Carbonero, Gracher, Komura, et al.,
2008), and Pleurotus pulmonarius (Smiderle et al., 2008), respectively.
A. bisporus white button mushroom constitutes the bulk of
all mushrooms consumed and contains bioactive compounds that
have been shown to exhibit immunomodulating and anticancer
A.C. Ruthes et al. / Carbohydrate Polymers 92 (2013) 184–191
properties (Adams, Phung, Wu, Ki, & Chen, 2008; Jeong,
Koyyalamudi, & Pang, 2012; Jeong, Sundar, Jeong, Song, & Gerald,
2012; Zhihong, Zhuyan, Nikbin, & Dayong, 2008), besides have
presented an effect against sepsis, possibly related to antiinflammatory potential of its polysaccharide (heterogalactan)
(Ruthes et al., 2012). Until this moment, there are very few reports
dealing with the ability of mushroom polysaccharides in reducing mortality caused by sepsis in mice. Sepsis is a considerable
health problem and a leading cause of morbidity and mortality in
many intensive care units. It represents a state of overproduction of
pro-inflammatory mediators which frequently occurs after various
noxious injuries, especially bacterial infection, as a consequence of
abdominal surgery, appendicitis, perforated ulcers, or an ischemic
bowel (Angus et al., 2001).
Thus, in order to compare chemical structure with biological properties of mushroom polysaccharides, another A. bisporus
fucogalactan was characterized. Its antinociceptive and antiinflammatory effects on neurogenic and inflammatory phases of
formalin-induced pain, besides of activity against murine sepsis,
namely its effects on lethality, neutrophil migration and proinflammatory proteins expression were also investigated.
2. Materials and methods
2.1. Biological material
Dried fruiting bodies of A. bisporus (champignon de Paris)
were provided by Makoto Yamashita Company (Miriam Harumi
Yamashita), Sao José dos Pinhais, State of Paraná, Brazil.
2.2. Extraction and purification of fucogalactans
Extraction of crude polysaccharides and their purification was
carried out as in Fig. 1A. Wiley-milled powder fruiting bodies
from A. bisporus (100 g) were extracted with H2 O at 4 ◦ C for 6 h
(6×; 2000 ml). The combined aq. extracts were added to excess
ethanol (EtOH, 3:1, v/v) to precipitate polysaccharides, which were
collected by centrifugation (8000 rpm at 5 ◦ C for 20 min). Polysaccharide fraction was then dissolved in H2 O, dialyzed against tap
water for 24 h to remove low-molecular-weight carbohydrates,
giving rise to a solution containing a fraction, denominated CWAb. This was frozen and then allowed to thaw slowly (Gorin &
Iacomini, 1984), resulting in an insoluble fraction ICW-Ab, which
was separated by centrifugation as described above. The supernatant fraction SCW-Ab, was treated with Fehling solution (Jones &
Stoodley, 1965), giving precipitated Cu2+ complex (FP-Ab), which
was separated by centrifugation. The precipitate was neutralized
with acetic acid (HOAc), dialyzed against tap water (48 h), deionized
with mixed ion exchange resins, and then freeze-dried.
FP-Ab fraction was further purified by closed dialysis through a
membrane with a 100 kDa Mr cut-off (Spectra/Por® Cellulose Ester),
giving rise to a retained (RFP-Ab) and an eluted (EFP-Ab) material
(Fig. 1A).
2.3. Monosaccharide composition of polysaccharides
Each polysaccharide fraction (1 mg) was hydrolyzed with 2 M
TFA at 100 ◦ C for 8 h, followed by evaporation to dryness. The
residues were successively reduced with NaBH4 (1 mg) and acetylated with Ac2 O-pyridine (1:1, v/v; 200 l) at 100 ◦ C for 30 min
following the method of Sassaki et al. (2008). The resulting alditol
acetates were analyzed by gas chromatography–mass spectrometry (GC–MS), using a Varian model 3300 gas chromatograph
linked to a Finnigan Ion-Trap, Model 810-R12 mass spectrometer. Incorporated was a DB-225 capillary column (30 m × 0.25 mm
i.d.) programmed from 50 to 220 ◦ C at 40 ◦ C min−1 , then hold, and
185
the alditol acetates identified by their typical retention times and
electron impact profiles.
2.4. Determination of homogeneity of polysaccharides and their
molecular weight (Mw )
The homogeneity and molecular mass (Mw ) of the purified
fucogalactan EFP-Ab were determined by high performance steric
exclusion chromatography (HPSEC), using a refractive index (RI)
detector. The eluent was 0.1 M NaNO3 , containing 0.5 g l−1 NaN3 .
The polysaccharide solutions were filtered through a membrane
with 0.22 m diameter pores (Millipore). The specific refractive
index increment (dn/dc) was determined using a Waters 2410
detector, the samples being dissolved in the eluent, five increasing concentrations, ranging from 0.2 to 1.0 mg ml−1 being used to
determine the slope of the increment.
2.5. Methylation analysis of fucogalactan
Per-O-methylation of isolated polysaccharide (EFP-Ab; 10 mg)
was carried out using NaOH–Me2 SO–MeI (Ciucanu & Kerek, 1984).
The process, after isolation of the products by neutralization
(HOAc), dialysis, and evaporation was repeated, and the methylation was found to be complete. The per-O-methylated derivatives
were hydrolyzed with 45% aqueous formic acid (HCO2 H, 1 ml) for
6 h at 100 ◦ C, followed by NaB2 H4 reduction and acetylation as
above (Section 2.3), to give a mixture of partially O-methylated
alditol acetates, which was analyzed by GC–MS using a Varian model 4000 gas chromatograph, equipped with fused silica
capillary columns of CP-Sil-43CB. The injector temperature was
maintained at 220 ◦ C, with the oven starting at 50 ◦ C (hold 2 min)
to 90 ◦ C (20 ◦ C min−1 , then held for 1 min), 180 ◦ C (5 ◦ C min−1 , then
held for 2 min) and to 220 ◦ C (3 ◦ C min−1 , then held for 5 min).
Helium was used as carrier gas at a flow rate of 1.0 ml min−1 . Partially O-methylated alditol acetates were identified from m/z of
their positive ions, by comparison with standards, the results being
expressed as a relative percentage of each component (Sassaki,
Gorin, Souza, Czelusniak, & Iacomini, 2005).
2.6. Nuclear magnetic resonance (NMR) spectroscopy
Mono- (13 C, 1 H and DEPT) and bidimensional NMR spectra
(HMQC, COSY, and coupled HMQC) were prepared using a 400 MHz
Bruker model DRX Avance spectrometer incorporating Fourier
transform. Analyses were carried out at 70 ◦ C on samples dissolved in D2 O. Chemical shifts are expressed in ı relative to acetone
at ı 32.77 (13 C) and 2.21 (1 H), based on DSS (2,2-dimethyl-2silapentane-5-sulfonate-d6 sodium salt; ı = 0.0 for 13 C and 1 H).
2.7. Biological activity
2.7.1. Experimental animals
Male Swiss mice (25–35 g) provided from Universidade Federal do Paraná (UFPR) and Universidade Federal de Santa Catarina
(UFSC) facilities were kept in a temperature controlled room
(20 ± 2 ◦ C) on a 12-h light–dark cycle (light on from 6:00 h). Food
and water were freely available. The experiments were performed
after approval of the protocol by the Institutional Ethics Committee of the UFPR (sepsis model, CEUA/BIO-UFPR, protocol number
529) and the UFSC (formalin model, CEUA-UFSC, protocol number PP00682). All experiments were conducted in accordance with
the current guidelines for the care of laboratory animals and the
ethical guidelines for the investigation of experimental pain in conscious animals (Zimmermann, 1983). The numbers of animals and
186
A.C. Ruthes et al. / Carbohydrate Polymers 92 (2013) 184–191
Fig. 1. (A) Scheme of extraction and purification of A. bisporus (Ab) fucogalactan. (B) Elution profile of fraction EFP-Ab determined by HPSEC using light scattering (· · ·) and
refractive index detectors (–).
intensities of noxious stimuli used were the minimum necessary to
demonstrate consistent effects of the drug treatments.
2.7.2. Nociception induced by intraplantar injection of formalin
The procedure used was similar to a previously described protocol (Santos & Calixto, 1997). The mice received 20 l of a 2.5%
formalin solution (0.92% formaldehyde) in saline via an intraplantar
(i.pl.) injection in the ventral surface of the right hindpaw. Animals were pretreated with vehicle (saline, 10 ml kg−1 , i.p.), EFP-Ab
(10, 30 and 100 mg kg−1 ) or dexamethasone (0.5, 5 and 10 mg kg−1 )
30 min before the formalin injection. Following the intraplantar
injection of formalin, the mice were immediately placed in a glass
cylinder (20 cm diameter), and the time spent licking the injected
paw was recorded with chronometer for both the early neurogenic
phase (0–5 min) and late inflammatory phase (15–30 min) of this
model. These values were considered measures of nociception.
2.7.3. Procedure to induce sepsis by cecal ligation and puncture
(CLP)
Mice were randomly divided into five groups with 10
mice/group: sham-operation, CLP plus saline (10 ml kg−1 s.c.), CLP
plus EFP-Ab (30 mg kg−1 s.c.), CLP plus EFP-Ab (100 mg kg−1 s.c.)
and CLP plus dexamethasone (0.5 mg kg−1 s.c.). Saline was used
as vehicle for dissolving the polysaccharide; and dexamethasone
was commercially purchased. It was administered 60 l of each
treatment solution, regarding the corporeal weigh of the animals (∼30 g). Ketamine (80 mg kg−1 ) and xylazine (20 mg kg−1 )
were injected intraperitoneally to anesthetize the mice before the
surgical procedures. Polymicrobial sepsis was induced by CLP as
previously described (Rittirsch, Huber-Lang, Flierl, & Ward, 2009).
A midline incision about ∼1.5 cm was performed on the abdomen.
The cecum was carefully isolated and the distal 50% was ligated.
The cecum was then punctured twice with a sterile 16-gauge needle and squeezed to extrude the fecal material from the wounds.
The cecum was replaced and the abdomen was closed in two layers. Sham-control animals were treated identically, but no cecal
ligation or puncture was carried out. Each mouse received subcutaneous sterile saline injection (1 ml) for fluid resuscitation after
surgery. The mice were then placed on a heating pad until they
recovered from the anesthesia. Food and water ad libitum were
provided throughout the experiment. Survival was monitored for
7 days, each 12 h. During this period, saline and drugs were subcutaneously administered daily.
In other experiments, during the surgery, mice were treated
subcutaneously with saline, EFP-Ab or dexamethasone. After 6 h
post-operation, mice were sacrificed. Their tissues from lungs and
small intestines (ileum) were collected and frozen for later use
to determine the myeloperoxidase (MPO) activity and iNOS and
COX-2 expression.
2.7.4. Lung MPO activity
MPO activity, assessment measure of neutrophil influx,
was determined according to established protocols (Bradley,
Priebat, Christensen, & Rothstein, 1982). Briefly, lung tissue was
A.C. Ruthes et al. / Carbohydrate Polymers 92 (2013) 184–191
Fig. 2.
13
C NMR spectrum of the fucogalactan EFP-Ab (A) with insert of its DEPT
homogenized in 0.5 ml of 50 mM potassium buffer pH 6.0 with
0.5% hexadecyltrimethylammonium bromide, sonicated on ice, and
then centrifuged at 14,000 rpm at 4 ◦ C for 15 min. Supernatants
were then assayed at a 1:20 dilution in reaction buffer (9.6 mM
3,3,5,5-tetramethylbenzine, 150 nmol l−1 H2 O2 in 50 mM potassium phosphate buffer), and read at 620 nm. Results are expressed
as change in optical density per milligram of protein (measured by
Bradford assay).
2.7.5. Western blot analysis
The ileum samples were washed twice with PBS and then
homogenated and lysed in extraction buffer [composition in
mM: Tris/HCl 20 (pH 7.5; QBiogene), NaCl 150, Na3 VO4 , sodium
pyrophosphate 10, NaF 20, okadaic acid 0.01 (Sigma), a tablet
of protease inhibitor (Roche) and 1% Triton X-100 (QBiogen)].
Total protein (20 g) was separated on 8% SDS–polyacrylamide
(Sigma) gels at 80 V for 2 h. Isolated proteins were transferred
electrophoretically onto polyvinylidine difluoride membranes
(Bio-Rad) at 100 V for 120 min. Membranes were blocked with
blocking buffer containing 3% low fat milk powder, Tris-buffered
saline solution (Bio-Rad) and 0.1% Tween 20 (Sigma) (TBS-T) for
1 h. Membranes were then incubated with the primary antibodies of either iNOS or COX-2 (dilution of 1:1000), overnight at
4 ◦ C. After washing, membranes were incubated with the secondary antibody (peroxidase-labeled anti-mouse IgG, dilution of
1:5000) at room temperature for 60 min. Detection of -tubulin
proteins was used for normalization and quantification of iNOS
and COX-2. Prestained markers (Invitrogen) were used for molecular mass determinations. Immunoreactive bands were detected by
enhanced chemiluminescence (Bio-Rad).
2.7.6. Statistical analysis
Data are presented as means ± standard error of the mean
(S.E.M.), except for the ID50 values (i.e., the dose of EFP-Ab necessary
to reduce the nociceptive response by 50% relative to the control
value), which are reported as geometric means accompanied by
their respective 95% confidence limits. The ID50 values were determined by nonlinear regression from individual experiments using
linear regression with GraphPad software (GraphPad software, San
Diego, CA, USA). Comparisons between experimental and control
groups were performed by one-way analysis of variance (ANOVA)
187
CH2 inversion (A′ ), in D2 O at 70 ◦ C (chemical shifts are expressed in ı ppm).
followed by Bonferroni’s or Newman–Keuls’ tests. P values less than
0.05 were considered as indicative of significance.
3. Results and discussion
3.1. Fucogalactans structural characterization
In order to obtain pure heteropolysaccharides from the fruiting
bodies of A. bisporus, they were submitted to aqueous extraction at
4 ◦ C. The extracted polysaccharides were precipitated with excess
ethanol, obtained as sediments on ultracentrifugation, dialyzed
against tap water, and the solution freeze-dried to give CW-Ab
(55.3 g) (Fig. 1).
Fractionation and purification of CW-Ab was carried out by
a freeze–thawing procedure, resulting in a respective cold-water
soluble SCW-Ab (43.4 g) and insoluble fraction (11.9 g). Fraction
SCW-Ab contained fucose, xylose, galactose, glucose and 3-Omethyl-galactose (confirmed by the presence of the fragments m/z
130 and 190, after hydrolysis, reduction with NaB2 H4 and acetylation) (Ruthes et al., 2012), but gave a heterogeneous HPSEC
elution profile, so it was then treated with Fehling solution. Its
respective insoluble Cu2+ complex FP-Ab (2.1 g) was further purified by closed dialysis through a 100 kDa Mr cut-off membrane.
This procedure gave rise to a retained RFP-Ab (0.2 g) and an eluted
EFP-Ab (1.9 g) fraction, respectively (Fig. 1A). The EFP-Ab fraction
was homogeneous on HPSEC, and had Mw 37.1 × 104 g mol−1 (dn/dc
0.148 ml g−1 ) (Fig. 1B).
As well as previously described for fraction RFP-Ab (Ruthes et al.,
2012), EFP-Ab also consists of a fucogalactan, composed of fucose
(11.2%), galactose (74.2%) and 3-O-methyl-galactose (14.6%).
EFP-Ab was submitted to methylation analysis, where GC–MS
of resulting O-methylalditol acetates showed the presence of
a branched structure, containing mainly, nonreducing end-units
of Fucp (2,3,4-Me3 Fuc; 13.1%), besides the 6-O-(2,3,4-Me3 Gal;
65.6%) and 2,6-di-O-substituted units (3,4-Me2 Gal; 17.4%) of dgalactopyranose. Small amounts of non-reducing end-units of Galp
(2,3,4,6-Me4 Gal; 3.9%) was also observed in the EFP-Ab fraction.
The ratio of units of Fucp: 2,6-di-O-Galp: 6-O-Galp was ∼1:1:5 for
EFP-Ab from A. bisporus. This relation was also confirmed by the
integration of H-1 signals (5.10:5.06:5.01) present in the 1 H NMR
spectrum (data not shown).
In order to elucidate the fucogalactan (EFP-Ab) structure, additional NMR spectroscopy [1 H, 13 C and DEPT (Fig. 2A and A′ ,
A.C. Ruthes et al. / Carbohydrate Polymers 92 (2013) 184–191
188
Table 1
1
H and 13 C NMR chemical shifts [expressed as ı (ppm)] of A. bisporus fucogalactan (EFP-Ab).a
Units
1
2
3
4
5
6
6a
13
␣-Fucp-(1→
1
-Galp-(1→
1
2,6→)-␣-Galp-(1→
1
6→)-␣-Galp-(1→
1
C
H
13
C
H
13
C
H
13
C
H
13
6→)-3-O-Me-␣-Galp-(1→
a
1
C
H
O CH3
6b
103.9
5.10
72.0
3.85
71.2
3.84
74.5
3.85
69.9
4.20
18.2
1.27
–
–
–
–
106.3
5.01
73.6
3.90
76.1
3.79
71.1
4.08
78.3
3.58
63.7
3.80
–
–
–
–
100.7
5.06
80.3
3.84
71.1
4.08
71.2
4.09
71.7
4.21
69.7
3.70
69.7
4.01
–
–
100.7
5.01
71.1
3.84
72.4
3.89
72.4
4.03
71.7
4.21
69.4
3.72
69.4
3.93
–
–
100.6
5.01
70.1
3.88
81.6
3.58
68.2
4.30
71.7
4.21
69.4
3.72
69.4
3.93
58.9
3.43
Assignments are based on 13 C, 1 H, DEPT, COSY and HMQC examination.
respectively), HMQC (Fig. 3), COSY and coupled HMQC (data not
shown)] analysis was also useful (Table 1). 13 C NMR (Fig. 2A)
and HMQC spectrum (Fig. 3), both obtained using D2 O as solvent
at 70 ◦ C, have shown C-1/H-1 signals at ı 106.3/4.64, 103.9/5.10,
100.7/5.06, 100.7/5.01, 100.6/5.01, which could be attributed to Galp, Fucp, Galp 2,6-di-O- and 6-O-substituted, and 3-O-Me-Galp
units, respectively.
The glycosidic configuration was confirmed by the coupling
constants values JC-1/H-1 found in 1 H/13 C-coupled HMQC spectrum.
The nonreducing end- of Fucp and the main-chain units (Galp or
3-O-Me-Galp or both) had the ␣-configuration due to respective
JC-1/H-1 162.6 Hz and 172.6 Hz, while those of nonreducing endunits of Galp from EFP-Ab had -configuration, consistent with
JC-1/H-1 161.3 Hz (Perlin & Casu, 1969).
The presence of 6-O- and 2-O-substituted Galp units as indicated
by methylation analysis was confirmed by NMR spectroscopy.
O-Substituted C-2 signal could be observed at ı 80.3 (Figs. 2 and 3),
while signals of CH2 groups of the 6-O-(Galp and 3-O-Me-Galp)
and 2,6-di-O-subst. (Galp) units of the main chain appears at ı
69.4/69.7 and 70.0, respectively, giving rise to inverted signals
in the DEPT spectrum (Fig. 2A′ ). The presence and position of
O-methyl groups of the A. bisporus fucogalactan was confirmed
by the presence of signal at ı 58.9/3.43 and ı 81.6/3.58 (C/H)
corresponding to OCH3 and O-substituted C-3 substituted/H-3,
respectively (Figs. 2 and 3 and Table 1).
The signals at ı 72.0/3.85, 71.2/3.84, 74.5/3.85, 69.9/4.20 and
d 18.2/1.27 could be attributed to C-2/H-2 to C-6/H-6 of Fucp
units, respectively, while those at ı 70.1/3.88, 81.6/3.58, 68.2/4.30,
71.7/4.21 and d 69.4/69.7/3.72/3.93 were from C-2/H-2 to C-6/H6 of 3-O-Me-Galp units (Figs. 2 and 3 and Table 1). -Galp units
also have their C-2/H-2 to C-6/H-6 signals attributed to those at
ı 73.6/3.90, 76.1/3.79, 71.1/4.08, 78.3/3.58 and 63.7/3.80, respectively (Table 1).
EFP-Ab fucogalactan analysis showed it to consist essentially of
a (1→6)-linked ␣-d-galactopyranosyl main-chain, partially substituted at O-2 by nonreducing end-units of ␣-l-Fucp. Although its
main chain showed to be partially O-methylated and had some
-d-Galp nonreducing end-units as substituents.
Fucogalactans similar to those now described have been isolated from cultivated mycelium of Coprinus comatus (Fan et al.,
2006), fruiting bodies of Sarcodon aspratus (Mizuno et al., 2000),
Hericium erinaceus (Zhang et al., 2006), A. brasiliensis and A. bisporus var. Hortensis (Komura et al., 2010) and from Lactarius rufus
and A. bisporus (Ruthes et al., 2012). The fucogalactana described
in the present work shows a great similarity to the previously one
described for the same mushroom (Ruthes et al., 2012). However,
it has a lower content of nonreducing end-units of -Galp. In this
way, EFP-Ab fucogalactan now characterized appears more similar
with that from A. bisporus var. hortensis (Komura et al., 2010).
Since A. bisporus var. hortensis represents A. bisporus when
mature, commonly known as Portobello mushroom, one may suggest that the fucogalactan as described in this paper is present in
both the young stage of the mushroom, and in its mature phase, i.e.,
its structure is not affected by A. bisporus fruiting body maturation.
3.2. Biological activities of EFP-Ab
Fig. 3. 1 H (obs.)/13 C HMQC spectrum of A. bisporus (A) fucogalactan EFP-Ab, in D2 O
at 70 ◦ C. Insert of CH3 -6 region from Fucp units (A′ ) (chemical shifts are expressed
in ı ppm).
It was previously demonstrated that fucogalactans exhibited
protective effects against sepsis and antinociceptive and antiinflammatory activities in mice (Komura et al., 2010; Ruthes et al.,
2012). In this study, we evaluated if the fucogalactan isolated from
A. bisporus also presented these properties.
In the present study, we demonstrated that EFP-Ab has a significant antinociceptive effect on formalin-induced pain in mice,
a classical chemical model of nociception. The results reported
here indicate that intraperitoneal administration of EFP-Ab produced significant inhibition of both the neurogenic (0–5 min)
and inflammatory (15–30 min) phases of formalin-induced licking.
However, the antinociceptive effect was significantly more pronounced against the second phase of this model of pain (Fig. 4A
and B). The mean ID50 values calculated for these effects were >100
A.C. Ruthes et al. / Carbohydrate Polymers 92 (2013) 184–191
A
100
B
350
280
*
60
40
Licking (s)
Licking (s)
80
20
210
**
140
***
70
0
0
C
10
30
C
100
-1
100
30
D
400
Licking (s)
320
60
40
20
100
EFP-Ab (mg.kg , i.p.)
80
Licking (s)
10
-1
EFP-Ab (mg.kg , i.p.)
C
189
*
240
160
80
0
0
C
0.5
5
10
Dexamethasone
(mg.kg-1, i.p.)
C
0.5
5
10
Dexamethasone
(mg.kg-1, i.p.)
Fig. 4. Effect of EFP-Ab (panels A and B) or dexamethasone (panels C and D) administered by intraperitoneal (i.p.) injection against formalin-induced nociception (neurogenic
phase, panels A and C, and second phase, panels B and D) in mice. Each group represents the mean of 6–8 animals and the error lines indicate the S.E.M. The control group
(C, black bars), indicates the mice treated by intraperitoneal (i.p.) injection with vehicle (10 ml kg−1 ) before formalin. The symbols *p < 0.05, **p < 0.01 and ***p < 0.001 denote
the significance level when compared to the control group. One way ANOVA followed by the Newman–Keuls’ test.
and 36.0 (25.8–50.3) mg kg−1 and the inhibitions observed were
29 ± 5% and 82 ± 9% at a dose of 100 mg kg−1 , for neurogenic and
inflammatory phases, respectively (Fig. 4A and B).
The formalin test is a satisfactory and comprehensive model
for evaluating the antinociceptive activity of drugs. The intraplantar injection of formalin activates nociceptive nerve terminals and
produces neurogenic pain, whereas inflammatory pain is mediated
by a combination of peripheral input and spinal cord sensitization
(Hunskaar & Hole, 1987; Tjølsen, Berge, Hunskaar, Rosland, & Hole,
1992). Moreover, it has been demonstrated that the intraplantar
injection of formalin in rodents increases spinal levels of excitatory amino acids, PGE2 , nitric oxide, tachykinin, kinins, among
other peptides (Malmberg & Yaksh, 1995; Santos & Calixto, 1997;
Santos, Vedana, & De Freitas, 1998; Tjølsen et al., 1992). Experimental data indicate that formalin predominantly evokes activity
in C-fibers peroxidase (Tjølsen et al., 1992), although A␦-fibers
are thought to be responsible for fast nociceptive transmission
in the first phase of the pain response (Julius & Basbaum, 2001).
It is notable that the nociception produced by formalin (neurogenic phase) is quite resistant to the majority of NSAIDs, such
as acetylsalicylic acid, indomethacin, paracetamol, and diclofenac.
However, these drugs can dose-dependently attenuate the inflammatory phase of formalin-induced licking (Hunskaar & Hole, 1987;
Malmberg & Yaksh, 1992; Santos et al., 1998). Here, we also demonstrated that dexamethasone, a synthetic glucocorticoid, was only
able to significantly inhibit (33 ± 6%) inflammatory pain induced
by formalin in high dose (10 mg kg−1 ) (Fig. 4C and D). Thus, our
study provides evidence that EFP-Ab inhibited both phases of formalin test but was more effective against the inflammatory pain,
which is different from the effect induced by dexamethasone; this
data led us to investigate its anti-sepsis effect.
It is believed that sepsis may lead to aberrant host inflammatory
responses, causing cell injury and organ dysfunction. Furthermore,
neutrophil infiltration is an important pathophysiologic alteration
associated with sepsis and these cells cause directly damage to
the tissues by releasing pro-inflammatory mediators, as cytokines,
superoxide-derived free radicals and lysosomal enzymes, such as
MPO, which amplify the systemic inflammatory response and cause
multiple organ failure (Landry & Oliver, 2001). In the present study,
a polymicrobial sepsis was induced by cecal ligation and puncture
(CLP) in mice to investigate the effects of EFP-Ab. The results of the
survival experiments are shown in Fig. 5A. Mice treated with vehicle started to die between 12 h and 24 h after CLP, with a death rate
reaching 37.8% and 87.5% after 24 h and 96 h post-CLP, respectively.
The overall mortality in this group, at the end of the observation
period, was 100%, and the corresponding area under the curve was
3.720 (arbitrary units). The lethality was markedly delayed in mice
treated subcutaneously with EFP-Ab. Their areas under the curve
were increased to 9.060 and 11.160 after treating with EFP-Ab 30
and 100 mg kg−1 , respectively. At the end of the study, the overall
survival in these EFP-Ab groups was 30% and 40%. Dexamethasonetreated mice showed a significant improvement in survival (area
under curve 10.100), with an overall survival rate of 16.7% at the end
of the observation period. No death occurred in the sham-operated
mice and its corresponding value for area under the lethality curve
was 16.800 (arbitrary units). This result could be attributable to an
anti-inflammatory activity, which is consistent with previous study
provided by our group (Komura et al., 2010; Ruthes et al., 2012).
As commented above, MPO is a lysosomal enzyme, produced by
polymorphonuclear leukocytes, and related to the production of
hypochlorous acid (powerful oxidant). For this reason, the effects
of EFP-Ab treatment on MPO activity were also investigated. Sepsis
CLP surgery markedly increased lung tissue MPO levels compared
with Sham group (45%) (Fig. 5B). This increasing in tissue MPO
was significantly prevented by EFP-Ab 30 and 100 mg kg−1 , with
an inhibition of 17.5% and 39.8%, respectively, vs. vehicle group.
190
A.C. Ruthes et al. / Carbohydrate Polymers 92 (2013) 184–191
Fig. 5. EFP-Ab protects against sepsis-induced lethality (A), inhibits myeloperoxidase activity (B) and reduces iNOS and COX-2 tissue expression, determined by Western
blot (C). The panels (a) and (b) are corresponding to the representative immunoblots iNOS and COX-2, respectively. Mice were subcutaneously administered EFP-Ab (30
and/or 100 mg kg−1 ), vehicle (saline) or dexamethasone (0.5 mg kg−1 s.c.). Values represent means ± S.E.M. of 4–10 animals/group. *p < 0.05 and ***p < 0.001 versus vehicle;
###
p < 0.001 versus sham;◦ ◦ ◦ p < 0.001 versus EFP-Ab 30 mg kg−1 . ANOVA followed by Bonferroni’s test.
Dexamethasone, the anti-inflammatory drug used as positive control, strongly inhibited the MPO activity in lungs (42.3%). Therefore,
it was observed that EFP-Ab prevented the elevation of MPO activity, indirectly indicating reductions in both neutrophil recruitment
to lungs and in oxidative tissue damage. This is of particular relevance because oxidative stress is known as a probable mechanism
for gut mucosal barrier dysfunction during sepsis condition, amplifying and perpetuating the initial systemic inflammatory responses
(Pastores, Katz, & Kvetan, 1996).
In this study, we also examined the effects of EFP-Ab on iNOS and
COX-2 expression in ileum of septic mice by immunoblotting. EFPAb 100 mg kg−1 decreased both iNOS and COX-2 expression by 53%
and 54%, respectively [Fig. 5C, panels (a) and (b)]. Dexametasone
also affected both iNOS and COX-2 expression, reducing by 74.5%
and 71.4%, respectively. These results strongly confirmed the antiinflammatory activity of EFP-Ab.
The enzymes iNOS and COX-2 are both upper expressed during pro-inflammatory events including sepsis. The iNOS (inducible
nitric oxide synthase), once expressed, produces high amounts of
NO over long periods of time, which causes cellular damage. It is
also associated with the septic shock, considered the main cause
of mortality among the septic patients (Landry & Oliver, 2001).
Compounds that inhibit iNOS expression or iNOS activity have antiinflammatory properties (Tinker & Wallace, 2006). In turn, COX-2 is
the inducible isoform of the cyclooxygenase enzyme that catalyzes
the production of inflammatory prostanoids. Systemic COX-2 is
increasingly recognized as an important player in sepsis-induced
inflammation. In fact, COX-2-deficient mice are protected from
sepsis-induced inflammation and death (Ejima et al., 2003).
4. Conclusions
In conclusion, we observed that EFP-Ab presented antinociceptive and anti-inflammatory activities against formalin-induced
nociception with more pronounced effect on inflammatory phase.
In addition, EFP-Ab can prevent the lethality caused by polymicrobial sepsis in mice. This beneficial effect seems to be, at least in
part, due to a reduction in neutrophil infiltration with consequent
protection against tissue damage, and also due to an inhibition on
iNOS and COX-2 tissue expression.
Acknowledgments
The authors would like to thank the Brazilian funding agencies:
CAPES (Coordenação de Aperfeiçoamento de Pessoal de Nível Superior), CNPq (Conselho Nacional de Desenvolvimento Científico e
Tecnológico), and Fundação Araucária for financial support.
References
Adams, L. S., Phung, S., Wu, X., Ki, L., & Chen, S. (2008). White button mushroom (Agaricus bisporus) exhibits antiproliferative and proapoptotic properties and inhibits
prostate tumor growth in athymic mice. Nutrition and Cancer, 60, 744–756.
Angus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., & Pinsky, M. R.
(2001). Epidemiology of severe sepsis in the United States: Analysis of incidence,
outcome, and associated costs of care. Critical Care Medicine, 29, 1303–1310.
Bradley, P. P., Priebat, D. A., Christensen, R. D., & Rothstein, G. (1982). Measurement
of cutaneous inflammation: Estimation of neutrophil content with an enzyme
marker. Journal of Investigative Dermatology, 78, 206–209.
Carbonero, E. R., Gracher, A. H. P., Komura, D. L., Marcon, R., Freitas, C. S., Baggio,
C. H., et al. (2008). Lentinus edodes heterogalactan: Antinociceptive and antiinflammatory effects. Food Chemistry, 111, 531–537.
Carbonero, E. R., Gracher, A. H., Rosa, M. C., Torri, G., Sassaki, G. L., Gorin, P. A. J., et al.
(2008). Unusual partially 3-O-methylated alpha-galactan from mushrooms of
the genus Pleurotus. Phytochemistry, 69, 252–257.
Ciucanu, I., & Kerek, F. (1984). A simple and rapid method for the permethylation of
carbohydrates. Carbohydrate Research, 131, 209–217.
Dore, C. M. P. G., Azevedo, T. C. G., Souza, M. C. R., Rego, L. A., Dantas, J. C.
M., Silva, F. R. F., et al. (2007). Antiinflammatory, antioxidant and cytotoxic
actions of -glucan-rich extract from Geastrum saccatum mushroom. International Immunopharmacology, 7, 1160–1169.
Ejima, K., Layne, M. D., Carvajal, I. M., Kritek, P. A., Baron, R. M., Chen, Y. H., et al.
(2003). Cyclooxygenase-2 deficient mice are resistant to endotoxin-induced
inflammation and death. The FASEB Journal, 17, 1325–1327.
A.C. Ruthes et al. / Carbohydrate Polymers 92 (2013) 184–191
Fan, J., Zhang, J., Tang, Q., Liu, Y., Zhang, A., & Pan, Y. (2006). Structural elucidation
of a neutral fucogalactan from the mycelium of Coprinus comatus. Carbohydrate
Research, 341, 1130–1134.
Gorin, P. A. J., & Iacomini, M. (1984). Polysaccharides of the lichens Cetraria islandica
and Ramalina usnea. Carbohydrate Research, 128, 119–131.
Hunskaar, S., & Hole, K. (1987). The formalin test in mice: Dissociation between
inflammatory and non-inflammatory pain. Pain, 30, 103–114.
Jeong, S. C., Koyyalamudi, S. R., & Pang, G. (2012). Dietary intake of Agaricus bisporus
white button mushroom accelerates salivary immunoglobulin A secretion in
healthy volunteers. Nutrition, 28, 527–531.
Jeong, S. C., Sundar, R. K., Jeong, Y. T., Song, C. H., & Gerald, P. (2012). Macrophage
immunostimulating and antitumour activities of polysaccharides isolated from
Agaricus bisporus white button mushroom. Journal of Medicinal Food, 15, 58–65.
Jones, J. K. N., & Stoodley, R. J. (1965). Fractionation using copper complexes. Methods
in Carbohydrate Chemistry, 5, 36–38.
Julius, D., & Basbaum, A. I. (2001). Molecular mechanisms of nociception. Nature,
413, 203–210.
Komura, D. L., Carbonero, E. R., Gracher, A. H., Baggio, C. H., Freitas, C. S.,
Marcon, R., et al. (2010). Structure of Agaricus spp. fucogalactans and their
anti-inflammatory and antinociceptive properties. Bioresource Technology, 101,
6192–6199.
Landry, D. W., & Oliver, J. A. (2001). The pathogenesis of vasodilatory shock. The New
England Journal of Medicine, 345, 588–595.
Lindequist, U., Niedermeyer, T. H., & Julich, W. D. (2005). The pharmacological potential of mushrooms. Evidence-based Complementary and Alternative Medicine, 2,
285–299.
Malmberg, A. B., & Yaksh, T. L. (1992). Antinociceptive actions of spinal nonsteroidal
anti-inflammatory agents on the formalin test in the rat. Journal of Pharmacology
and Experimental Therapeutics, 263, 136–146.
Malmberg, A. B., & Yaksh, T. L. (1995). Cyclooxygenase inhibition and the spinal
release of prostaglandin E2 and amino acids evoked by paw formalin injection:
A microdialysis study in unanesthetized rats. The Journal of Neuroscience, 15,
2768–2776.
Mizuno, M., Shiomi, Y., Minato, K., Kawakami, S., Ashida, H., & Tsuchida, H. (2000).
Fucogalactan isolated from Sarcodon aspratus elicits release of tumor necrosis
factor-a and nitric oxide from murine macrophages. Immunopharmacology, 46,
121–133.
Moradali, M. F., Mostafavi, H., Ghods, S., & Hedjaroude, G. A. (2007). Immunomodulating and anticancer agents in the realm of macromycetes fungi (macrofungi).
International Immunopharmacology, 7, 701–724.
Moro, C., Palacios, I., Lozano, M., D’Arrigo, M., Guillamón, E., Villares, A., et al. (2012).
Anti-inflammatory activity of methanolic extracts from edible mushrooms in
LPS activated RAW 264.7 macrophages. Food Chemistry, 130, 350–355.
Pastores, S. M., Katz, D. P., & Kvetan, V. (1996). Splanchnic ischemia and gut mucosal
injury in sepsis and the multiple organ dysfunction syndrome. American Journal
of Gastroenterology, 91, 1697–1710.
Perlin, A. S., & Casu, B. (1969). Carbon-13 and proton magnetic resonance spectra of
d-glucose-13 C. Tetrahedron Letters, 34, 2919–2924.
Poucheret, P., Fons, F., & Rapior, S. (2006). Biological and pharmacological activity of higher fungi: 20-Year retrospective analysis. Cryptogamie Mycologie, 27,
311–333.
Queiroz, L. S., Nascimento, M. S., Cruz, A. K. M., Castro, A. J. G., Moura, M. F. V., Baseia,
I. G., et al. (2010). Glucans from the Caripia montagnei mushroom present antiinflammatory activity. International Immunopharmacology, 10, 34–42.
Rittirsch, D., Huber-Lang, M. S., Flierl, M. A., & Ward, P. A. (2009). Immunodesign of
experimental sepsis by cecal ligation and puncture. Nature Protocols, 4, 31–36.
191
Rosado, F. R., Carbonero, E. R., Claudino, R. F., Tischer, C. A., Kemmelmeier, C., &
Iacomini, M. (2003). The presence of partially 3-O-methylated mannogalactan
from the fruit bodies of edible basidiomycetes Pleurotus ostreatus ‘florida’ Berk.
and Pleurotus ostreatoroseus Sing. FEMS Microbiology Letters, 221, 119–124.
Ruthes, A. C., Rattmann, Y. D., Carbonero, E. R., Gorin, P. A. J., & Iacomini, M. (2012).
Structural characterization and protective effect against murine sepsis of fucogalactans from Agaricus bisporus and Lactarius rufus. Carbohydrate Polymers, 87,
1620–1627.
Santos, A. R. S., & Calixto, J. B. (1997). Further evidence for the involvement of
tachykinin receptor subtypes in formalin and capsaicin models of pain in mice.
Neuropeptides, 31, 381–389.
Santos, A. R. S., Vedana, E. M. A., & De Freitas, G. A. G. (1998). Antinociceptive effect
of meloxicam, in neurogenic and inflammatory nociceptive models in mice.
Inflammation Research, 47, 302–307.
Sassaki, G. L., Gorin, P. A. J., Souza, L. M., Czelusniak, P. A., & Iacomini, M. (2005).
Rapid synthesis of partially O-methylated alditol acetate standards for GC–MS:
Some relative activities of hydroxyl groups of methyl glycopyranosides on Purdie methylation. Carbohydrate Research, 340, 731–739.
Sassaki, G. L., Souza, L. M., Serrato, R. V., Cipriani, T. R., Gorin, P. A. J., & Iacomini, M.
(2008). Application of acetate derivatives for gas chromatography mass spectrometry: Novel approaches on carbohydrates, lipids and amino acids analysis.
Journal of Chromatography A, 1208, 215–222.
Smiderle, F. R., Carbonero, E. R., Mellinger, C. G., Sassaki, G. L., Gorin, P. A. J., & Iacomini, M. (2006). Structural characterization of a polysaccharide and a -glucan
isolated from the edible mushroom Flammulina velutipes. Phytochemistry, 67,
2189–2196.
Smiderle, F. R., Olsen, L. M., Carbonero, E. R., Marcon, R., Baggio, C. H., Freitas, C.
S., et al. (2008). A 3-O-methylated mannogalactan from Pleurotus pulmonarius:
Structure and antinociceptive effect. Phytochemistry, 69, 2731–2736.
Tinker, A. C., & Wallace, A. V. (2006). Selective inhibitors of inducible nitric oxide
synthase: Potential agents for the treatment of inflammatory diseases? Current
Topics in Medicinal Chemistry, 6, 77–92.
Tjølsen, A., Berge, O. G., Hunskaar, S., Rosland, J. H., & Hole, K. (1992). The formalin
test: An evaluation of the method. Pain, 51, 5–17.
Wasser, S. P. (2002). Medicinal mushrooms as a source of antitumor and
immunomodulating polysaccharides. Applied Microbiology and Biotechnology,
60, 274–285.
Wasser, S. P. (2010). Current findings, future trends, and unsolved problems in
studies of medicinal mushrooms. Applied Microbiology and Biotechnology, 89,
1321–1332.
Wasser, S. P., & Weis, A. L. (1999). Therapeutic effects of substances occurring in
higher Basidiomycetes mushrooms: A modern perspective. Critical Reviews in
Immunology, 19, 65–96.
Zhang, A. Q., Zhang, J. S., Tang, Q. J., Jia, W., Yang, Y., Liu, Y. F., et al. (2006). Structural
elucidation of a novel fucogalactan that contains 3-O-methyl rhamnose isolated
from the fruiting bodies of the fungus, Hericium erinaceus. Carbohydrate Research,
341, 645–649.
Zhang, M., Cui, S. W., Cheung, P. C. K., & Wang, Q. (2007). Antitumor polysaccharide from mushrooms: A review on their isolation process, structural
characteristics and antitumor activity. Trends in Food Science and Technology, 18,
4–19.
Zhihong, R., Zhuyan, G., Nikbin, S., & Dayong, W. (2008). White button mushroom
enhances maturation of bone-marrow-derived dendritic cells and their antigenpresenting function in mice. Journal of Nutrition, 138, 544–550.
Zimmermann, M. (1983). Ethical guidelines for investigations of experimental pain
in conscious animals. Pain, 16, 109–110.